- Home
- / Universal Ibogaine
Universal Ibogaine
Stock Price
$0
2024-10-29
Market Capitalization
$4.6 M
2024-10-29
Revenue
$2.3 M
FY, 2024
Universal Ibogaine Summary
Company Summary
- Overview
- Universal Ibogaine is a life sciences company that develops, acquires, and operates addiction treatment clinics. It provides drug treatment and rehabilitation services.
- Type
- Public
- Status
- Active
- Founded
- 2017
- Cybersecurity rating
Table of Contents
Universal Ibogaine Financials
Summary Financials
- Revenue (Q3, 2025)
- $C700.0K
- Gross profit (Q3, 2025)
- $C700.0K
- Net income (Q3, 2025)
- ($C66.0K)
- Cash (Q3, 2025)
- $C128.0K
- EBIT (Q3, 2025)
- ($C33.0K)
- Enterprise value
- $7.0M
Footer menu
Product
- Intelligence Suite
- Supplier Intelligence Platform
- Craft Intelligence Portal
- Craft API
- Craft for Teams
- Supplier Intelligence Platform
- Craft Alerts
- Craft N-Tier Mapping
- Craft Risk Hub
- Chrome extension
Resources
© Craft.co 2026